Stavanger University Hospital, Department of Ophthalmology
Stavanger, 4016, Norway
NCT Number: NCT03187613
Individuals operated for rhegmatogenous retinal detachment will be prospectively evaluated for postoperative retinal shift. Fundus autofluorescence will be used to evaluate retinal shift that will be correlated to visual acuity, metamorphopsia, aniseikonia, and stereopsis.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Stavanger, 4016, Norway
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 2 years
Measured on fundus autofluorescence
Time frame: 6 and 24 months
Best Corrected Visual Acuity
Time frame: 6 and 24 months
M-Chart
Time frame: 6 and 24 months
New Aniseikonia Test
Time frame: 6 and 24 months
Titmus Test
Helse Stavanger HF
Other Gov
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04089033
Aniseikonia, Eye Diseases
Toronto, Ontario, Canada
View Trial DetailsNCT03902795
Eye Diseases, Nervous System Diseases
Lublin, Poland
View Trial DetailsNCT04676256
Eye Diseases, Retinal Break
Paris, Île-de-France Region, France
View Trial DetailsNCT01767038
Eye Diseases, Retinal Detachment
Besançon, France
View Trial Details